SCHEMBL7882185

SCHEMBL7882185

CCN(CC)Cc1ccc(COc2cc(C(F)(F)F)c3cc(C(=O)N=C(N)NC)[nH]c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.37
MAOB P27338 5/20 0.35
AR P10275 5/20 0.34
MCHR1 Q99705 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
BCHE P06276 1/20 0.32
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31
MMP13 P45452 1/20 0.31
RHEB Q15382 1/20 0.31
IDO1 P14902 1/20 0.31
TDO2 P48775 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877573 0.93 GYS1 (0.36) HRH3L3MBTL1MAOBARKDM4E
SCHEMBL7879946 0.91 MAOB (0.35) MAOBARMCHR1RHEBACHE
SCHEMBL7879952 0.90 RHEB (0.35) HRH3ARRHEBACHE
SCHEMBL7877982 0.88 MAOB (0.37) MAOBARRHEBIDO1TDO2
SCHEMBL7881849 0.88 MAOB (0.36) MAOBARBCHEACHE
SCHEMBL7881488 0.88 HRH3 (0.42) HRH3L3MBTL1MAOBMCHR1KDM4E
Hydrochloric Acid SCHEMBL7881834 0.87 IDO1 (0.40) MAOBARKDM4EALDH1A1RHEB
SCHEMBL7873709 0.85 HRH3 (0.47) HRH3L3MBTL1MAOBKDM4EALDH1A1
SCHEMBL7881348 0.85 ALK (0.36) HRH3MAOBARMAPTSMN1; SMN2
SCHEMBL7877875 0.85 RHEB (0.34) ARBCHERHEBACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed